Daphne Quimi, Chief Financial Officer at AMICUS THERAPEUTICS, INC. (FOLD), sold 4,396 shares at $9.00 ($40K) on 2022-06-17, disclosed to the SEC on 2022-06-21.
Scheduled sale ($40k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2023-01-19 | $152K | — | Filing → |
| FOLD | SELL | 2022-09-06 | $50K | — | Filing → |
| FOLD | SELL | 2022-08-09 | $70K | — | Filing → |